Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The C-terminal region of <i>Opisthorchis viverrini</i> granulin-1 promotes cell proliferation in the absence of regular secondary structure.

Australian journal of chemistry·2026
Same author

Transcriptional profiling of the Crocodylus porosus liver cell response to Kunjin virus reveal novel insights into the host-virus interface.

Microbial pathogenesis·2026
Same author

A novel hookworm vaccine candidate identified through immunomic profiling of human protective immunity.

International journal for parasitology·2026
Same author

Transgenic hookworm secretes anti-tetrodotoxin human single chain antibody.

Nature communications·2026
Same author

Advances in vaccine development through the controlled human infection models for hookworm and schistosomiasis.

PLoS neglected tropical diseases·2026
Same author

Optimized hookworm-derived biologic, AIP-2<sub>NTQ48</sub> restores mucosal tolerance and down-regulates colon cancer-associated gene expression in TNBS-induced colitis.

Mucosal immunology·2026

Related Experiment Video

Updated: May 17, 2026

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Peptide-based subunit vaccine against hookworm infection.

Mariusz Skwarczynski1, Annette M Dougall, Makan Khoshnejad

  • 1The University of Queensland, School of Chemistry and Molecular Biosciences, St. Lucia, Queensland, Australia.

Plos One
|October 12, 2012
PubMed
Summary

Developing a new vaccine against hookworm infection is crucial due to widespread disease and treatment limitations. A novel Lipid Core Peptide (LCP) construct effectively induced enzyme-neutralizing antibodies in mice, offering a promising vaccine strategy.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Related Experiment Videos

Last Updated: May 17, 2026

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Area of Science:

  • Parasitology
  • Vaccinology
  • Biochemistry

Background:

  • Hookworm infections affect millions globally, causing debilitating diseases with limited treatment efficacy and frequent re-infections.
  • There is an urgent need for effective vaccines against hookworm parasites like Necator americanus.

Purpose of the Study:

  • To develop a self-adjuvanting vaccine candidate targeting the Necator americanus aspartic protease Na-APR-1.
  • To evaluate the immunogenicity and efficacy of a novel engineered epitope construct in a mouse model.

Main Methods:

  • An alpha helical epitope (A(291)Y) from Na-APR-1 was engineered and incorporated into a Lipid Core Peptide (LCP) system.
  • The LCP-epitope construct was administered to mice, and IgG responses and antibody neutralization activity against Na-APR-1 were assessed.

Main Results:

  • The LCP construct induced a strong IgG response in mice, unlike the peptide alone or with traditional adjuvants.
  • The generated antibodies effectively bound to and completely inhibited the enzymatic activity of Na-APR-1.

Conclusions:

  • The novel chimeric LCP construct is a promising self-adjuvanting vaccine platform for inducing enzyme-neutralizing antibodies.
  • This approach holds potential for developing vaccines against helminth parasites in humans and animals.